Collaborative Meeting at BIOCEV, FGÚ, and Brain4Industry Focuses on Nanotechnology Partnerships

On September 26, 2024, a significant series of meetings took place at BIOCEV in Vestec, the Institute of Physiology of the Czech Academy of Sciences (FGÚ) in Prague-Krč, and the Brain4Industry (B4I) hub in Dolní Břežany. The discussions focused on advancing collaborations in nanotechnology and biomedical research, with the involvement of several key institutions. Karel Havlíček represented Nanoprogress during these meetings, playing a pivotal role in shaping future cooperation.
The day began at BIOCEV, where doc. Milan Jakubek, the head of the Laboratory of Medicinal Chemistry, presented the ongoing research on the biological availability of active substances. During this session, it was agreed that Nanoprogress would supply nanofiber layers with specific properties for biological testing, paving the way for further tests on nano-forms of various compounds developed by Nanoprogress.
At the Institute of Physiology, doc. Lucie Bačáková and her team explored the possibilities of using nanotechnology in biomaterials and tissue engineering, with particular interest in 3D bioprinting. A joint project was proposed to focus on printing specific tissue structures and leveraging nanofiber layers to support cell growth. Further meetings were scheduled to solidify this collaboration and prepare a detailed project proposal.
The final stop at Brain4Industry involved discussions with Ing. Jana De Merlier, CEO of STAR Cluster, and her colleagues. They introduced the B4I initiative, emphasizing the professional training of SME employees. A training session for Nanoprogress staff was agreed upon, along with plans to expand these offerings to companies within the Nanoprogress cluster. Before concluding the event, attendees toured the laser centers in Dolní Břežany, with additional meetings planned for the future to explore potential synergies.
Throughout the day, Nanoprogress, represented by Karel Havlíček, played a key role in fostering these strategic partnerships, aiming to advance innovations in nanotechnology and biomedicine across these prominent institutions.